Skip to content

Veracyte VCYT Total Cost of Revenue

Total Cost of Revenue at other companies

Guardant Health logo
Guardant HealthGH
$104.92M+40.4%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$282.7M+1.2%
Labcorp Holdings logo
Labcorp HoldingsLH
$2.52B+5.3%
Quest Diagnostics logo
Quest DiagnosticsDGX
$1.95B+9.2%
Natera, Inc. logo
Natera, Inc.NTRA
Revvity logo
RevvityRVTY

Segments

By product

See full
Testing revenue$33.31M+17.9%

Other financials

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation

See full
Market cap$4.29B+10.7%

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0.0×
Current ratio9.3×+4.2×

Where this comes from

Reported directly by Veracyte in its filing.

Tagged under the XBRL concept us-gaap:CostOfRevenue.

The official record: Veracyte’s 10-K, filed February 25, 2020, on SEC EDGAR. View the filing →

Questions, answered.

What does total cost of revenue mean?
The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.